Abstract
The effects of baclofen on the development of reverse tolerance and postsynaptic dopamine receptor supersensitivity induced by morphine were examined in mice. A single administration of morphine induced hyperactivity and the morphine-induced hyperactivity was inhibited dose dependently by the administration of a GABAB receptor agonist, baclofen (1.25, 2.5 and 5 mg kg-1, i.p.). Daily repeated administration of morphine developed reverse tolerance to the hyperactivity of morphine. The concomitant administration of baclofen inhibited the morphine-induced hyperactivity and the baclofen administration prior to and during the chronic administration of morphine in mice inhibited the development of reverse tolerance to the hyperactivity of morphine (10 mg kg-1, s.c.). Postsynaptic dopamine receptor supersensitivity was also developed in reverse-tolerant mice that had received the same morphine. The development of postsynaptic dopamine receptor supersensitivity was evidenced by the enhanced ambulatory activity of apomorphine (2 mg kg-1, s.c.). Baclofen also inhibited the development of postsynaptic dopamine receptor supersensitivity induced by the chronic administration of morphine. These results suggest that the hyperactivity, reverse tolerance and postsynaptic dopamine receptor supersensitivity induced by morphine may be modulated via the activation of GABAB receptors induced by baclofen.
Original language | English |
---|---|
Pages (from-to) | 335-340 |
Number of pages | 6 |
Journal | Pharmacological Research |
Volume | 43 |
Issue number | 4 |
DOIs | |
State | Published - 2001 |
Bibliographical note
Funding Information:The authors wish to acknowledge the financial support of the Brain Korea 21 project of the Ministry of Education, Republic of Korea.
Keywords
- Baclofen
- Hyperactivity
- Morphine
- Postsynaptic dopamine receptor supersensitivity
- Reverse tolerance